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Cyclin D1, p16, and retinoblastoma gene regulate mitogenic signaling
of endothelin in rat mesangial cells. To elucidate the mechanisms by
which endothelin (ET)-1 induces proliferation of mesangial cells, we
investigated the involvement of the first gap phase of the cell cycle (G1)
cyclin, cyclin-dependent kinase 4 (CDK4) activity, and the retinoblastoma
gene product (pRb) in ET-1-stimulated cell cycle progression. In the
present study, ET-1 stimulated CDK4 activity and cell cycle progression
via ET A-type receptors and induced cyclin D1 mRNA and protein
expression in rat mesangial cells. We also found that ET-1 stimulation of
mesangial cell proliferation was inhibited by antisense oligonucleotides
directed against cyclin D1 and by overexpression of a nonphosphorylat-
able form of pRb. To investigate the functional roles of p16INK4 and
p21cip1 in ET-1-stimulated mesangial cell proliferation, we used adenovi-
rus-mediated gene transfer. Endothelin-1-stimulated [3H]-thymidine in-
corporation, CDK4 kinase activity, and the percent of cells in S phase were
found to be significantly inhibited by overexpression of p16INK4 and
slightly inhibited by overexpression of p21cip1. Thus, ET-1 induced cyclin
D1 expression and stimulated CDK4 activity and cell cycle progression via
the A-type receptor in rat mesangial cells. These effects were regulated by
the expression of cyclin D1, p16INK4, p21cip1, and phosphorylatable form
of pRb. The results of the present study provide the basis for further
investigation of basic and therapeutic approaches towards mesangial
proliferative diseases.
Endothelin is a secreted 21 aminoacid peptide that was first
discovered as a potent vasoconstrictor in supernatants of cultured
vascular endothelial cells. Endothelin-1 (ET-1) has both contrac-
tile and mitogenic actions in mesangial cells [1–3]. Proliferation of
glomerular mesangial cells is a common feature of many glomer-
ular diseases [4, 5]. Yoshimura et al noted that up-regulation in
glomerular ET-1 mRNA and protein in Thy-1 induced experimen-
tal glomerulonephritis [6]. Furthermore, ET A-receptor antago-
nists were reported to protect against renal disease progression [7,
8]. Recently, Hocher et al reported that ET-1 transgenic mice
develop glomerulosclerosis leading to a progressive decrease in
the glomerular filtration rate [9]. In human proliferative glomer-
ulonephritis including IgA nephropathy, urinary ET-1 excretion
and ET-1 mRNA expression in peripheral blood monocytes
increased [10]. Therefore, it has been suspected that ET-1 syn-
thesis or ET-1 metabolism may play an important role in the
pathogenesis of mesangial proliferative glomerulonephritis. Inves-
tigation of the regulatory mechanisms of cell cycle progression of
mesangial cells induced by ET-1 will contribute to our under-
standing of the pathophysiology of mesangial proliferative glo-
merulonephritis.
Eukaryotic cell growth is tightly regulated through a precise
balance of positive and negative regulatory components that exert
their effects during the first gap phase (G1) of the cell cycle [11,
12]. The most critical positive-acting components are G1 cyclins
[12, 13]. When quiescent cells are stimulated to re-enter the cell
cycle, G1 cyclins (three types of cyclin D and cyclin E) are induced
and their associated kinases are activated. This leads to the
phosphorylation of downstream targets such as retinoblastoma
gene product (pRb). The activity of these G1 cyclin kinases is
modulated by at least two distinct families of cyclin-dependent
kinase (CDK) inhibitors in mammalian cells: the p21/p27 family
and p16/p18 family [12, 14–21]. There appear to be several
functional and structural differences between the p21/p27 family
and p16/p18 family.
In mesangial cells, the mitogenetic response to ET-1 is reported
to involve tyrosine phosphorylation, c-fos induction, and activa-
tion of AP-1 binding site [1, 22, 23]. However, little is known about
the contribution of G1 cyclin, CDK inhibitors, and pRb in
ET-1-stimulated transition of G0 to G1/S. The regulatory role of
the p21/p27 family and p16/p18 family in the ET-1-stimulated
mitogenetic pathway remains to be clarified.
In this study, we hypothesize that cyclin D1/CDK4 complex,
pRb, p16INK4, and p21cip1 participate in the pathway of ET-1-
induced proliferation in mesangial cells. We demonstrate that
ET-1 stimulates cyclin D1 expression, and that ET-1-stimulated
mesangial cell proliferation is inhibited by antisense oligonucleo-
tides directed against cyclin D1, overexpression of p16INK4, and
unphosphorylated mutant Rb protein.
METHODS
Construction of recombinant adenoviruses
Replication-defective, recombinant adenovirus AxCAp16 and
AxCAp21 were constructed by homologous recombination be-
tween the expression cosmid cassette and the parental virus
genome. Adex1w is a 42 kb cosmid containing the 31 kb adeno-
virus type 5 genome lacking the E1A, E1B, and E3 genes. The
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expression cosmid cassette and adenovirus DNA-terminal protein
complex (DNA-TPC) were cotransfected into 293 cells by the
calcium phosphate precipitation method. Adex1w and DNA-TPC
were kindly provided by Dr. I. Saito [24]. The full-length human
p16 cDNA (0.7 kb; kindly provided by Dr. Ed Harlow) [25] was
isolated by restriction enzyme digested with BamHI, and then
ligated into the expression cosmid cassette using the method
reported previously by Kanegae et al [24]. The full-length rat p21
cDNA (2.1 kb; kindly provided by Dr. A. Noda) [15] was isolated
by restriction enzyme digested with BamHI, and then ligated into
the expression cosmid cassette. The recombinant unphosphory-
lated Rb protein adenovirus (AxmtRb) was generously provided
by Dr. E. Barr (University of Chicago, Chicago, IL, USA) [26].
AxmtRb encodes a hemagglutinin (HA)-epitope-tagged nonphos-
phorylatable mutant form of the human Rb gene product [26]. A
recombinant adenovirus expressing the LacZ gene (AxCALacZ)
was kindly provided by Dr. I. Saito [24]. Each adenovirus prepa-
ration was titrated by plaque-assay on 293 cells.
Mesangial cell culture
Mesangial cell strains from male Sprague-Dawley rats were
isolated and characterized as previously reported [27]. Cells were
maintained in RPMI1640 medium supplemented with 20% fetal
bovine serum, 100 units/ml penicillin, 100 mg/ml streptomycin, 5
mg/ml of insulin, 5 mg/ml of transferrin, and 5 ng/ml selenite at
37°C in a 5% CO2 incubator. The cells used in experiments were
from passages 4 to 9. The cells were subcultured in 10 cm dishes
or 24-well dishes at a density of 5 3 104 cells/ml, incubated in
medium plus 20% FCS until ;80% confluence, and then incu-
bated in medium plus 0.25% FCS for 24 hours before infection.
After removal of the medium, the viral solution was added to the
culture dishes for one hour, with shaking every 20 minutes.
Subsequently, the cells were incubated in medium plus 0.25%
FCS for 48 hours, and then incubated in a medium containing
indicated concentrations of ET-1 for the indicated times.
Receptor antagonists and antibodies
Endothelin A-type receptor (ETAR)-specific antagonist, BQ-
123, and B-type receptor (ETBR)-specific antagonist, BQ-788,
were purchased from Banyu Chemical (Tokyo, Japan). Antibodies
against anti-mouse-cyclin D1, anti-mouse-cyclin D2, anti-mouse-
cyclin D3, anti-human-Rb, anti-mouse-CDK4, and anti-human-
pRb were purchased from Santa Cruz Biotechnology (Santa Cruz,
CA, USA). Antibodies against anti-human-p21cip1 and anti-hu-
man-p16INK4 were purchased from Pharmigen (San Diego, CA,
USA).
Northern blot analysis
mRNA was extracted from the mesangial cells using TRI-
REAGENT (Life Technologies, Gaithersburg, MD, USA). Fif-
teen migrogram (total RNA) samples were separated on 1%
agarose-formaldehyde-MOPS gels and transferred to Hybond-N
hybridization membranes (Amersham, Arlington Heights, IL,
USA). A 2.1 kb full-length human p21 [15] cDNA, 0.7 kb
full-length human p16 [25, 28] cDNA, and 1.3 kb full-length
mouse cyclin D1 [29] cDNA were labeled by the random priming
method and used as probes for Northern hybridization. Following
hybridization, the membranes were washed twice for five minutes
at room temperature in 5 3 SSPE and 0.5% SDS, twice at 37°C
for 15 minutes in 1 3 SSPE and 0.5% SDS, once at 37°C for 15
minutes in 0.1 3 SSPE and 0.5% SDS, and then exposed to Fuji
X-ray film (Fuji Photo Film, Kanagawa, Japan) for three to seven
days at 280°C.
Western blot analysis
The proteins were extracted from mesangial cells using TRI-
REAGENT. Pellets were solubilized in SDS-sample buffer. Fifty
micrograms of protein was resolved in SDS-polyacrylamide gel
electrophoresis, and the proteins were then transferred to an
Immobilon P membrane (Daiichikagaku, Tokyo, Japan). To de-
tect cyclin D1, cyclin D2, cyclin D3, p16, and p21, the membrane
was incubated with antibody at a dilution of 1:1000 in TBS
containing 0.1% Tween 20 for two hours at 37°C, and then
visualized using the ECL chemiluminescence system (Amer-
sham).
[3H] thymidine incorporation
Mesangial cells were plated in 24-well plates, incubated in
medium containing 0.25% FCS for 24 hours, and then transfected
with 20 MOI (multiplicity of infection) adenovirus for one hour.
Subsequently, the cells were incubated for 48 hours in 0.25% FCS
medium, and then in medium was changed to a medium contain-
ing 0.25%-FCS and various concentrations of ET-1 or ET-3
(Peptide Institute, Osaka Japan) for 18 hours. For the last four
hours, the cells were pulsed with 1 mCi [3H] thymidine (Amer-
sham). After the cells were washed three times in ice-cold PBS,
they were precipitated two times with 10% trichloroacetic acid
(TCA), redissolved in 0.5 M NaOH, and counted in Aquasol-2
scintillation cocktail (NEN Research Products, Boston, MA,
USA).
Cell cycle analysis
Mesangial cells were cultured in a 75 cm2 flask. The cells were
incubated in RPMI1640 medium plus 0.25% fetal calf serum
(FCS) for 24 hours before adenovirus infection. After removal of
medium, 20 MOI (multiplicity of infection) viral solutions were
added to the culture dishes for one hour, and the cells were then
incubated in medium containing 1028 M ET-1 for 24 hours. The
samples were washed twice with PBS and then resuspended in
70% ethanol for at least 12 hours at 4°C. Fixed and permeabilized
cells were collected by centrifugation and washed with PBS. The
cells were stained with propidium iodide and analyzed by flow
cytometry using a Coulter EPICS 753 flow cytometer, and the
percentages of the cells in the G1, S, and G2/M phases were
determined [29]. All experiments were repeated at least three
times.
Antisense oligonucleotide
Antisense oligonucleotide (oligonucleoside phosphorothioates)
against the first 15 nucleotides of the coding region of rat cyclin
D1 including the AUG codon (59GAGCTGGTGTTCCAT39)
were synthesized by a DNA synthesizer (Model 8909; PerSeptive
Biosystems) and purified by HPLC. Mismatches of oligonucleo-
tides at four nucleotides (59GACCAGGTCTACCAT39) were
similarly synthesized. The cells were incubated with antisense or
mismatched oligonucleotides (1025 M) for 18 hours immediately
before treatment with ET-1. Oligonucleotides were also added at
the start of ET-1 treatment.
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Cyclin-dependent kinase 4 assay
The immune complex kinase assay was performed using essen-
tially the same methods described by Matushime et al [30]. Cells
were suspended at 1 3 106 to 5 3 106/ml in buffer and sonicated
at 4°C (Sonicator, Daiichikagaku, Tokyo, Japan). Lysates were
clarified by centrifugation at 10,000 3 g for five minutes. Super-
natants were incubated for two hours at 4°C with 10 ml of
anti-mouse-CDK4 antibody and 20 ml of protein G-plus agarose
(Oncogene Science, Uniondale, NY, USA), and immune com-
plexes were recovered by centrifugation. Immunoprecipitated
proteins were suspended in 30 ml of kinase buffer (50 mM HEPES,
pH 7.5, 10 mM MgCl2, 1 mM DTT) containing substrate (0.2 mg of
soluble glutathione S-transferase-pRb fusion protein) and 2.5 mM
EGTA, 10 mM b-glycerophosphate, 1 mM NaF, 20 mM ATP, and
10 mCi of [gamma-32P] ATP (6,000 Ci/mmol; NEN, Dupont,
Boston, MA, USA). After incubation for 30 minutes at 30°C with
occasional mixing, the samples were boiled in polyacrylamide gel
sample buffer containing sodium dodecyl sulfate (SDS) and
separated by electrophoresis. Phosphorylated proteins were visu-
alized by autoradiography. Preparation of the pRb substrate was
performed using essentially the same method described by Mat-
sushime et al [30].
Statistical analysis
The results were given as means 6 SEM. The differences were
tested using analysis of variance. P , 0.05 was considered
significant.
RESULTS
Endothelin-1 and endothelin-A receptor
Endothelin-1 and ETA receptor stimulated [3H]-thymidine incor-
poration and CDK4 kinase activity in rat mesangial cells. To
measure the proliferative effects of ET-1 and ET-3, various
concentrations of ET-1 or ET-3 were added to quiescent mesan-
gial cells in medium containing 0.25% FCS for 18 hours. [3H]-
thymidine incorporation was then measured. As shown in Figure
1A, ET-1 but not ET-3 caused a dose-dependent increase in
[3H]-thymidine incorporation.
To determine which type of ET receptor is involved in the
ET-1-induced mesangial cell proliferation, we used the ETAR-
specific antagonist, BQ-123, and the ETBR-specific antagonist,
BQ-788. As shown in Figure 1B, BQ-123 significantly inhibited
ET-1 (1028 M)-induced [3H]-thymidine incorporation, whereas
BQ-788 did not. Next, we tested whether these effects were
mediated by CDK4 kinase activity. As shown in Figure 1C, ET-1
stimulated CDK4 kinase activity, and this effect was significantly
inhibited by BQ-123, but not by BQ-788. These results suggest
that ET-1, acting primarily through ETAR, stimulates CDK4
kinase activity and induces mesangial cell proliferation.
Endothelin-1 and cyclin D1 antisense oligonucleotide
Endothelin-1 stimulated cyclin D1 mRNA and protein expression,
and cyclin D1 antisense oligonucleotide inhibited ET-1-stimulated
mesangial cell proliferation. To investigate what kinds of D-type
cyclin are induced after ET-1 stimulation, Northern and Western
blot analyses were performed for cyclins D1, D2, and D3. While
the cyclin D1 mRNA increased from two hours after ET-1
stimulation until reaching its peak at four hours, the bands for
mRNA of cyclin D2 and cyclin D3 were very weak during
ET-1-stimulation and did not increase (Fig. 2A). Western blots
analyses revealed that the cyclin D1 band intensity of 34 kDa
increased from four hours and peaked at six hours. The bands for
cyclin D2 and cyclin D3 were not detected during ET-1 stimula-
tion (Fig. 2B). To determine whether other mitogenic stimuli
Fig. 1. Effect of endothelin (ET)-1, ET-3, BQ-123 and BQ-788 on [3H]
thymidine incorporation and CDK4 activity in mesangial cells. (A) After
incubation in medium containing 0.25% FCS for 48 hours, mesangial cells
were incubated with 10211 ;to 1027 M ET-1 (f) or ET-3 (M) for 18 hours,
and then pulsed with [3H] thymidine for the last four hours (N 5 5,
mean 6 SEM). (B) After incubation in 0.25% FCS-containing medium for
48 hours, mesangial cells were incubated with 1028 M ET-1 for 18 hours in
the presence of 1026 M BQ-123 or BQ-788, and then pulsed with [3H]
thymidine for four hours (N 5 5, mean 6 SEM). The control was quiescent
cells without stimulation by ET-1. (C) Lysate of mesangial cells that were
incubated with 1028 M ET-1 for 18 hours in the presence of 1026 M
BQ-123 or BQ-788 was immunoprecipitated with anti-CDK4 antibody.
Immune complexes were assayed for pRb kinase activity. The control was
quiescent cells without stimulation of ET-1.
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could induce these cyclins, Western blot analyses were performed
for cyclins D1, D2, and D3 after 12 hours incubation with 20%
FCS. In this experimental condition, cyclin D1 was substantially
inducible, and cyclin D3 was minimally induced. Cyclin D2 protein
was not detected either in the presence or absence of FCS (Fig.
2C). Thus, we focused on cyclin D1 for the antisense oligonucle-
otide experiments.
To further assess the possible involvement of cyclin D1 in
ET-1-stimulated proliferation, we introduced antisense oligonu-
cleotides against the coding region of cyclin D1 mRNA in rat
mesangial cells. Antisense oligonucleotides (1025 M) blocked
cyclin D1 protein expression to 25%, and mismatched oligonucle-
otides (1025 M) did not have any effect on ET-induced cyclin D1
protein expression (Fig. 2C). The antisense sequence (1025 M)
blocked [3H]-thymidine incorporation. The mismatch sequence
did not have any effect on ET-induced [3H]-thymidine incorpo-
ration (Fig. 2C). Cell cycle analysis by EPICS revealed that the
antisense sequence (1025 M) reduced the percentage of ET-1-
stimulated increment of S phase and G2/M phase (Fig. 2D).
Endothelin-1 and mutant retinoblastoma gene protein
Endothelin-1 stimulated phosphorylation of Rb protein, and inhi-
bition of ET-1-stimulated mesangial cell proliferation by overexpres-
sion of unphosphorylated mutant Rb protein. To determine the
involvement of Rb protein phosphorylation in ET-1 stimulated
mesangial proliferation, we examined phosphorylation of Rb
protein by ET-1, and the effects of AxmtRb in mesangial cell
growth. Endothelin-1 stimulated Rb phosphorylation. Retinoblas-
toma gene phosphorylation was inhibited by BQ-123, but not by
BQ-788 (Fig. 3A). We examined the effects of AxmtRb and the
control virus (AxCALacZ) infection on ET-1-induced DNA syn-
thesis (Fig. 3B). Endothelin-1 (1028 M) stimulated [3H]-thymidine
incorporation twofold over the control level, and this effect was
significantly inhibited by 20 MOIs of AxmtRb infection. Cell cycle
analysis by EPICS revealed that overexpression of mutant Rb
protein reduced the percentage of ET-1-stimulated increment of
S phase and G2/M phase (Fig. 3C).
Gene transfer of p16INK4 and p21cip1
Effect of gene transfer of p16INK4 (AxCAp16) and p21cip1 (Ax-
CAp21) on ET-1-stimulated cell cycle progression and CDK4 kinase
activity in mesangial cells. To evaluate the physiological signifi-
cance of p16INK4 and p21cip1 in mesangial cell cycle progression,
we performed Western blot analyses for p16INK4 and p21cip1 in
the presence and absence of ET-1(1028 M). When the cell cycle
Fig. 2. Endothelin (ET)-1 stimulation of
cyclin D1 mRNA and protein expression, and
inhibitory effects of cyclin D1 antisense
oligonucleotides on ET-1-stimulated
mesangial cell proliferation. (A) ET-1 (1028
M) was added to quiescent mesangial cells and
total RNA was extracted at indicated times.
Northern blot analysis was performed using
total RNA (15 mg). Filters were hybridized
with a specific cDNA probe for cyclin D1, D2,
and D3. Ribosomal RNA (18S) is shown as a
control for RNA loading. (B) ET-1 (1028 M)
was added to quiescent mesangial cells and
total cellular protein was extracted at
indicated times. Western blot analysis was
performed with a specific antibody for cyclins
D1, D2, or D3. (C) Western blot analysis was
performed with a specific antibody for cyclins
D1, D2, or D3 in the presence and absence of
20% FCS for 48 hours. Controls were
quiescent cells without stimulation by ET-1.
(D) After mesangial cells were pretreated
with antisense oligonucleotides (1025 M) or
oligonucleotides with a mismatched sequence
(1025 M) for 18 hours, they were exposed to
ET-1 (1028 M), and [3H]-thymidine
incorporation was measured (N 5 5, mean 6
SEM). Lower panel shows Western blot
analysis of cyclin D1 pretreated with antisense
oligonucleotides or mismatched
oligonucleotides. (E) After mesangial cells
were pretreated with antisense
oligonucleotides (1025 M) or oligonucleotides
with a mismatch sequence (1025 M) for 18
hours, they were exposed to ET-1 (1028 M)
and the cell cycle was analyzed by EPICS.
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was arrested in the absence of ET-1, the bands for p16INK4 and
p21cip1 were detectable, as shown in Figure 4A. The p16INK4 and
p21cip1 proteins were decreased in the presence of ET-1. Next, we
examined the effects of AxCAp16 and AxCAp21 infection on
ET-1-induced DNA synthesis (Fig. 4B). At 1028 M ET-1 stimu-
lated [3H]-thymidine incorporation twofold over the control level,
and this effect was significantly inhibited by 20 MOIs of AxCAp16
infection. AxCAp21 infection resulted in a smaller but statistically
significant inhibition of ET-1-stimulated [3H]-thymidine incorpo-
ration (Fig. 4B).
To further establish the involvement of p16INK4 and p21cip1 in
ET-1-induced mesangial cell proliferation, we measured CDK4
kinase activity. Endothelin-1 (1028 M) stimulated CDK4 kinase
activity. This stimulation was inhibited significantly by 20 MOIs of
AxCAp16, and inhibited slightly by 20 MOIs of AxCAp21 (Fig.
4C).
Next, we performed cell cycle analysis by EPICS of AxCAp16-
and AxCAp21-infected mesangial cells. The cell cycle distribution
of mesangial cells incubated with medium containing 0.25% FCS
for 48 hours showed a large number in the G1 population (Fig.
4D). Incubation with 1028 M ET-1 for 24 hours caused an increase
in the population in S phase and G2/M phase. AxCAp16 signifi-
cantly reduced the percentage of cells in S phase and G2/M phase
induced by 1028 M ET-1. AxCAp21 caused a slight but statistically
significant reduction of the percentage of S phase and G2/M
phase induced by 1028 M ET-1 (Fig. 4D).
We carefully observed the morphology and health of mesangial
cells infected with the adenovirus expressing p16INK4, p21cip1 and
unphosphorylated mutant pRb. We did not observe any significant
change in the morphology of the mesangial cells such as apoptosis.
All experiments were repeated at least three times.
DISCUSSION
In the present study, ET-1 stimulated CDK4 activity and cell
cycle progression via the ET A-type receptor, and induced cyclin
D1 mRNA expression in rat mesangial cells. Additionally, mes-
angial cell proliferation induced by ET-1 was inhibited by anti-
sense oligonucleotides against cyclin D1 and overexpression of a
nonphosphorylatable form of Rb protein. We observed that
ET-1-stimulated [3H]-thymidine incorporation and CDK4 kinase
activity, and that the percentage of cells in S phase was signifi-
cantly reduced by overexpression of p16INK4 and slightly reduced
by overexpression of p21cip1.
There are three types of D cyclin (D1, D2, and D3), and the
Fig. 3. Endothelin (ET)-1 stimulated
phosphorylation of Rb protein, and inhibition
of ET-1-stimulated mesangial cell proliferation
by overexpression of unphosphorylated mutant
Rb protein. (A) After incubation in 0.25% FCS-
containing medium for 48 hours, mesangial
cells were incubated with 1028 M ET-1 for 18
hours in the presence of 1026 M BQ-123 or
BQ-788, and total cellular protein was extracted
at the indicated times. Western blot analysis
was performed with a specific antibody for RB
protein. The control was quiescent cells without
stimulation by ET-1. (B) Mesangial cells were
infected with 20 MOIs (that is, multiplicity of
infection) of AxmtRb or AxCALacZ for one
hour, incubated with 1028 M ET-1 for 18 hours,
and then pulsed with [3H] thymidine for the last
four hours (N 5 5, mean 6 SEM). The control
was quiescent cells without stimulation by ET-1.
(C) Mesangial cells were infected with AxmtRb
(20 MOIs) for one hour, incubated with 1028 M
ET-1 for 18 hours, and then collected and
analyzed for DNA content by flow cytometry.
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role of each remains largely undefined. Endothelin-1 induced
expression of cyclin D1 mRNA and protein, but not cyclins D2 or
D3. Therefore, we investigated the functional role of cyclin D1 in
mesangial cells. D-type cyclins have been shown to associate with
their partner CDKs, primarily CDK4. D-type cyclins have a very
short half-life (;30 min), and their expression can be induced by
growth factors [29]. To our knowledge, this is the first report to
demonstrate that ET-1 increased cyclin D1 mRNA and protein
levels. Furthermore, we demonstrated in our studies using anti-
sense oligonucleotides that cyclin D1 expression is necessary for
ET-1-induced cell proliferation. These findings suggest that cyclin
D1 and CDK4 activity may be one of the nuclear targets of
proliferative signals by ET-1.
The mechanisms of cyclin D1 induction by ET-1 are not clear at
present. In intact rat glomeruli, both types of ET receptor are
expressed [31]. Both ETAR and ETBR are also expressed in
cultured glomerular mesangial cells [3, 27], and a large number of
studies have shown the mitogenic and contractile actions of ET-1
[1–3, 5, 32]. Although ETAR was reported to play a major role in
the mitogenetic function of ET-1 in mesangial cells, the intranu-
clear mechanisms are not well known. Our results are the first to
demonstrate that the ETAR mediates ET-1-stimulated cyclin D1
induction and activation of CDK4 in rat mesangial cells.
In our experiment, ET-1 stimulated cyclin D1 mRNA beginning
at two hours. The mechanism leading to this induction of cyclin
D1 appears to involve early response genes such as c-jun, c-fos,
and protein kinases [33]. Simonson et al reported that ET-1
transcriptionally activated c-fos mRNA expression and stimulated
MAP kinase cascades in rat mesangial cells [22, 34]. Further
studies will be necessary to determine the signal transduction
pathways from ETAR to cyclin D1 induction.
The functional role of pRb is not clearly known. Based on the
finding that incubation of cyclin D with CDK4/CDK6 and a pRB
fusion protein yielded phosphorylation of pRb in vitro, Kato et al
and Ewen et al speculated that the cyclin D/CDK4, CDK6
complex is a key kinase for phosphorylation of pRb [35, 36]. Lukas
Fig. 4. Effects of gene transfer of p16INK4
(AxCAp16) and p21cip1 (AxCAp21) on
endothelin (ET)-1-induced [3H] thymidine
incorporation and cyclin-dependent kinase 4
(CDK4) activity in mesangial cell proliferation.
(A) Western blot analysis was performed with a
specific antibody for p16INK4 and p21cip1 in the
presence and absence of 1028 M ET-1 for 48
hours. Control were quiescent cells without
stimulation by ET-1. (B) Mesangial cells were
infected with 20 MOIs of AxCAp16, AxCAp21,
or AxCALacZ for one hour, and the medium
was changed to medium containing 1028 M ET-
1 for 18 hours. For the last four hours, the cells
were pulsed with [3H] thymidine (N 5 5,
mean 6 SEM). The control was quiescent cells
without stimulation by ET-1. (C) Lysate of
mesangial cells infected with 20 MOIs
AxCAp16 or AxCAp21 was immunoprecipitated
with anti-CDK4 antibody. Immune complexes
were assayed for pRb kinase activity. The
control was quiescent cells without stimulation
by ET-1. (D) Mesangial cells were infected with
AxCAp16 (20 MOIs) or AxCAp21 (20 MOIs)
for one hour, exposed to ET-1 (1028 M) for 48
hours, and then examined for cell cycle analysis
by EPICS. The control was quiescent cells
without stimulation by ET-1.
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et al reported that antibody-mediated neutralization of cyclin D1
arrested Rb-positive cells in G1, whereas this neutralization of
cyclin D1 appeared to produce no effect in Rb-deficient cells [37].
These data provide evidence that pRb is a target of the cyclin D1
and CDK complex. Hypophosphorylated pRb binds to transcrip-
tion factors of the E2F family and prevents the transactivation of
target genes that promote cell cycle progression. pRb phosphor-
ylation during G1 has been shown to release E2F from this
inhibitory complex, and to facilitate entry into the S phase [11, 12].
To test the role of pRb in ET-1-stimulated mesangial cell
proliferation, we used an adenovirus vector containing a mutant
sequence of the nonphosphorylatable form of Rb (AxmtRb) [26].
Overexpression of the nonphosphorylatable form of Rb could
reduce free E2F and block the function of intrinsic pRB. This
vector has been shown to inhibit the restenosis of porcine femoral
arteries in vivo [26]. Overexpression of AxmtRb inhibited ET-1-
stimulated mesangial cell proliferation. This suggested that pRb
may be a nuclear target of proliferative signals induced by ET-1.
Retinoblastoma gene product (pRb) is reported to play an
important role in the differentiation of many cells [38–40]. Chen
et al reported that Rb directly interacts with and activates
NF-IL-6, a factor important for differentiation [38]. Myoblasts
derived from Rb-null mouse embryos fail to differentiate termi-
nally in culture [39, 40]. The role of pRb in mesangial cells in this
area is largely unexplored. Further studies will be necesarry to
clarify the many functional roles of pRb in mesangial cells.
To our knowledge, there have been no reports that demonstrate
the effects of p16INK4 and p21cip1 in ET-1-stimulated cell prolif-
eration. The activity of cyclin-CDK kinase is subjected to several
levels of regulation. One of these is through the action of cell cycle
inhibitors. Several of these inhibitors were isolated recently.
p21cip1 associates with G1 cyclins as well as the mitotic cyclins, and
may play an important role in the assembly of the cyclin-CDK
complexes and DNA replication [41]. Alternatively, a different
group of cell cycle inhibitors, p16INK4, can associate only with
CDK4 and CDK6 [14]. Since recombinant p16INK4 binds to CDK4
or CDK6 but not to cyclins or other known CDKs, it forms a
binary complex lacking kinase activity [28, 42]. The relative
abundance of p16INK4 and D-type cyclins might determine the
activity of the CDK4 kinase and regulate G1-phase progression.
Our results using EPICS demonstrate that overexpression of
p16INK4 significantly inhibits ET-1-induced transition of G0 to
G1/S and decreases CDK4 kinase activity in mesangial cells.
However, there is a plausible explanation for why the p21cip1
caused only a partial inhibition of ET-1-induced transition of G0
to G1/S. Recently it was shown that more than one molecule of
p21cip1 appears to be necessary for CDK kinase inhibition,
indicating that p21cip1 could be present in active cyclin-CDKs [41].
Thus, overexpression of p21cip1 may not simply inhibit CDK
kinase activity and cell cycle progression. We speculate that
p16INK4 is a major negative regulator in the control of ET-1-
stimulated transition of G0 to G1/S in rat mesangial cells.
In summary, ET-1 induced cyclin D1 mRNA, stimulated CDK4
activity, and cell cycle progression via the A-type receptor in rat
mesangial cells. These proliferative effects of ET-1 were inhibited
by antisense oligonucleotides against cyclin D1, and overexpres-
sion of a nonphosphorylatable form of Rb protein and p16INK4.
The results of the present study provide a basis for further
investigation of basic and therapeutic approaches in the study of
mesangial proliferative diseases. Further studies will be necessary
to clarify the physiological or pathogenetic mechanisms of cell
cycle control in mesangial cells.
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APPENDIX
Abbreviations used in this article are: ET, endothelin; pRB, retinoblas-
toma gene product; G1, first gap phase of the cell cycle; CDK, cyclin
dependent kinase; DNA-TPC, DNA-terminal protein complex; HA, hem-
agglutinin; AxCALacZ, adenovirus expressing the LacZ gene; ETAR,
endothelin A-type receptor; ETBR, endothelin type-B receptor; TCA,
trichloroacetic acid; SDS, sodium dodecyl sulfate; BQ-123, ETAR-specific
antagonist; BQ-788, ETBR-specific antagonist; MOIs, multiplicity of
infection.
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